These pathways are closely associated with hormone receptor signaling, oncogenic transcriptional regulation, and cellular proliferation, suggesting that O-desmethyltramadol may exert its effects in hormone receptor-positive breast cancer cells by modulating growth factor signaling and oncogene regulation. The gene discussed is NR4A1; the disease is breast cancer.